pI: 6.6731 |
Length (AA): 429 |
MW (Da): 47225 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 54 | 2xz2 (A) | 12 | 62 | 41.00 | 0 | 1 | 0.664712 | -0.71 |
76 | 425 | 6b3x (A) | 80 | 427 | 64.00 | 0 | 1 | 1.54275 | -0.65 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129724)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G60940 | transducin/WD40 domain-containing protein |
Babesia bovis | BBOV_II006860 | WD domain, G-beta repeat containing protein |
Brugia malayi | Bm1_43290 | Cleavage stimulation factor, 50 kDa subunit |
Caenorhabditis elegans | CELE_F28C6.3 | Protein CPF-1 |
Cryptosporidium hominis | Chro.40101 | Cstf1-prov protein |
Cryptosporidium parvum | cgd4_820 | WD repeat protein |
Dictyostelium discoideum | DDB_G0278769 | WD40 repeat-containing protein |
Drosophila melanogaster | Dmel_CG2261 | CG2261 gene product from transcript CG2261-RA |
Echinococcus granulosus | EgrG_000392300 | cleavage stimulation factor subunit 1 |
Echinococcus multilocularis | EmuJ_000392300 | cleavage stimulation factor subunit 1 |
Homo sapiens | 1477 | cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa |
Leishmania braziliensis | LbrM.33.0280 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_330300.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.33.0300 | hypothetical protein, conserved |
Leishmania major | LmjF.33.0280 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.32.0280 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_03033 | cleavage stimulation factor |
Mus musculus | ENSMUSG00000027498 | cleavage stimulation factor, 3' pre-RNA, subunit 1 |
Oryza sativa | 4334149 | Os03g0754900 |
Plasmodium berghei | PBANKA_1119700 | cleavage stimulation factor subunit 1, putative |
Plasmodium falciparum | PF3D7_0620500 | cleavage stimulation factor subunit 1, putative |
Plasmodium knowlesi | PKNH_1129700 | cleavage stimulation factor subunit 1, putative |
Plasmodium vivax | PVX_114150 | cleavage stimulation factor subunit 1, putative |
Plasmodium yoelii | PY04225 | hypothetical protein |
Schistosoma japonicum | Sjp_0209030 | similar to Cleavage stimulation factor 50 kDa subunit, putative |
Schistosoma mansoni | Smp_045250 | hypothetical protein |
Schmidtea mediterranea | mk4.001129.16 | Cleavage stimulation factor subunit 1 |
Schmidtea mediterranea | mk4.001129.10 | Cleavage stimulation factor subunit 1 |
Trypanosoma brucei gambiense | Tbg972.10.19280 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.15740 | hypothetical protein, conserved |
Trypanosoma congolense | TcIL3000_10_13520 | WD domain, G-beta repeat, putative |
Trypanosoma cruzi | TcCLB.508899.30 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.511365.10 | hypothetical protein, conserved |
Theileria parva | TP02_0661 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.15740 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.15740 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.15740 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.15740 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F28C6.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F28C6.3 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F28C6.3 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_1119700 | Plasmodium berghei | Slow | plasmo |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Gallus gallus | Serine-threonine protein phosphatase 2A regulatory subunit | 426 aa | 19.5% | 364 aa | Compounds | References |